Trial Profile
A Randomized, Double-blind, Cross-over, Placebo-controlled Study of Melatonin in Prophylactic Treatment of Migraine
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms MMP
- 06 Sep 2012 New source identified and integrated (NCT00849511: ClinicalTrials.gov: US National Institutes of Health).
- 02 Mar 2011 New trial record